Frozen embryos are an increasingly popular method of fertility treatment, in which embryos created through in vitro fertilization (IVF) are frozen and stored for later use. This method offers a number of advantages over traditional IVF, including increased success rates, cost savings, and improved safety. Frozen embryos are also becoming a popular choice for couples considering embryo donation or adoption. Embryos are typically frozen at the two to eight-cell stage, which is a few days after fertilization. This stage is considered optimal for freezing because the cells have not yet formed the protective outer shell that is needed for successful thawing and implantation. Once frozen, the embryos can be stored for long periods of time, typically up to 10 years. The process of freezing embryos is known as cryopreservation, and it involves exposing the embryos to extreme cold temperatures. This process kills any bacteria or other microorganisms that may be present, helping to ensure the safety and efficacy of the embryos. The success rates of frozen embryos are significantly higher than those of traditional IVF, particularly for women over the age of 35. This is likely because the embryos have been exposed to fewer chemicals and hormones than they would be in the traditional IVF process. Frozen embryos also offer a cost advantage over traditional IVF. Since the embryos can be stored for long periods of time, couples can purchase a "package" of embryos, rather than paying for multiple rounds of IVF. Finally, frozen embryos offer a greater sense of safety and control for couples considering embryo donation or adoption. Frozen embryos can be tested for genetic diseases or other abnormalities before they are implanted, allowing couples to make a more informed decision about the embryos they choose to use. In conclusion, frozen embryos offer numerous advantages over traditional IVF, including increased success rates, cost savings, and improved safety. For couples considering embryo donation or adoption, frozen embryos can also provide a greater sense of control and peace of mind.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia